SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

ABSTRACT Preexisting immunity to Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) was nonexistent in humans, which coupled with high transmission rates of …

Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual
characteristics influencing it, including the impact of pre-existing antibodies to human …

ABSTRACT The coronavirus disease 19 (COVID-19) pandemic continues to impose a
significant burden on global health infrastructure. While identification and containment of …

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are
needed to support clinical diagnosis and epidemiological investigations. Recently, assays …

Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-
2 monoclonal antibodies and vaccines currently used in clinical practice; broadly …

Numerous studies have shown that a prior SARS-CoV-2 infection can greatly enhance the
antibody response to COVID-19 vaccination, with this so called “hybrid immunity” leading to …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has now caused over 2 million …

Emerging SARS-CoV-2 variants of concern that overcome natural and vaccine-induced
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests …

It has been more than a year since severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) first emerged. Many studies have provided insights into the various aspects of the …